Man

Carlos Pablo Vio Lagos

Profesor

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

Líneas de Investigación


Pathogenesis and treatment of Hypertension and chronic renal diseases. Renal vasoactive hormones and hypertension. Dietary potassium/sodium and hypertension, Renal and cardiovascular physiology and pathology. Kidney development and regeneration.

Educación

  •  Medical Doctor, UNIVERSIDAD DE CHILE. Chile, 1976
  •  Medicina, UNIVERSIDAD AUSTRAL DE CHILE. Chile, 1975

Experiencia Académica

  •   Professor Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Ciencias Biologicas

    Santiago, Chile

    1986 - A la fecha

  •   Professor Full Time

    UNIVERSIDAD AUSTRAL DE CHILE

    Medicina

    Valdivia, Chile

    1977 - 1986

Experiencia Profesional

  •   General Director for Research, Graduate studies, and Centers Full Time

    Pontificia Universidad Catolica de Chile

    Santiago, Chile

    2000 - 2005

  •   Vice President for Research and Doctorate Full Time

    Pontificia Universidad Catolica de Chile

    Santiago, Chile

    2005 - 2010

Formación de Capital Humano


Ph.D. Thesis Director since year 2000.
1. Mariana Quiroz-Muñoz. Ph.D. 2016
“Dietary salt intake regulates Cyclooxygenase-2 via Prostaglandin E2 EP receptor in the Thick Ascending Limb of Henle. Contribution to sodium regulation in the kidney "
Ph.D, program in Medical Sciences, Pontificia Universidad Católica de Chile.
2. Catherina Cuevas G. Ph.D. 2014
“Regulación de la via Wnt por Ang II y Ang-(1-7): Participación en Fibrosis Renal"
Ph.D, program in Biological Sciences, Physiology, Pontificia Universidad Católica de Chile.
3. José Miguel Erpel N. Ph.D. 2014
"Inhibidores de la enzima convertidora de angiotensina I disminuyen el daño renal a través del aumento de ciclooxigenasa-2 vía JNK/cJun"
Ph.D, program in Biological Sciences, Physiology,, Pontificia Universidad Católica de Chile.
4. Alexis A. Gonzalez, Ph.D. 2008
“Expresión del canal de sodio epitelial (ENaC) en modelos de hipertensión y posible regulación mediada por COX-2 en riñón de rata”
Doctorado en Ciencias Biológicas, mención Ciencias Fisiológicas, Pontificia Universidad Católica de Chile.
5. Ulises Novoa, Ph.D. 2006
“Contribución de la Angiotensina 1-7 a la fibrosis tubulointersticial renal”
Ph.D, program in Biological Sciences, Physiology,. Pontificia Universidad Católica de Chile
6. Jorge A. Rodriguez, Ph.D. 2003
“Bradykinin regulates Cyclooxygenase-2”
Ph.D, program in Biological Sciences, Physiology,, Pontificia Universidad Católica de Chile.
7. Pedro Gallardo M, Ph.D. 2002
“Distribución y regulación de Acuaporinas de epitelios involucrados en la homeostasis hídrica”
Ph.D, program in Biological Sciences, Physiology,, Pontificia Universidad Católica de Chile.

Postdoctoral Supervisor (Patrocinante) since year 2000
1.Postdoctoral fellow. Sandra Villanueva, DVM, Ph.D. 2004-2006
"Expresión de proteínas nefrogénicas como modelo de reparación en la fase de regeneración de la insuficiencia renal aguda."
Pontificia Universidad Católica de Chile, Departamento de Fisiología
2. Postdoctoral fellow. Maria José Acuña T. 2014-2017
“Papel del Sistema Calicreina Cinina en la Fibrosis de Músculo Distrófico”, Pontificia Universidad Católica de Chile, Departamento de Fisiología
3. Postdoctoral fellow. Mariana Labarca L. 2016-2017
“Regulation of Sodium and potassium Channels and Transporters by Vasoactive Homones in Distal Tubule Cells”.
Pontificia Universidad Católica de Chile, Departamento de Fisiología
4. Postdoctoral fellow. Daniela Salas C. 2015-2018
“Efecto de la Dieta Sodio/Potasio sobre Mecanismos de Regulación Génica de Homonas Vasoactivas e Hipertensión Arterial”
Pontificia Universidad Católica de Chile, Departamento de Fisiología
5. Postdoctoral fellow. Jessica Díaz E. 2015-2018
“Estudios in vivo e in vitro del Efecto de Potasio y Litio sobre la Regulación de Homonas Vasoactivas en Función Renal”
Pontificia Universidad Católica de Chile, Departamento de Fisiología
7. Postdoctoral fellow. Natalia Mendez, DVM, Ph.D. 2016-2018
“Chronobiology of renal vasoactive hormones, dietary potassium, and hypertension”
Pontificia Universidad Católica de Chile, Departamento de Fisiología


Difusión y Transferencia


Contribution to Public Policies in Human health and Education of the Population.
1. Conference “Contribution of dietary potassium to human health: When removing the sodium salt it is not sufficient” to authorities of Ministry of Health, Hospital Directors, and Chilean Medical Association. Sept 28, 2016 at Auditorium in Ministry of Health.
2. The Catholic University selected a Public Policy Proposal entittled “Contribution of the dietary potassium to the prevention and control of hypertension. When decreasing the salt is not enough” as part of the agenda to be presented the Chilean Goverment. Under revison for publication.
3. "Hypertension, the kidney under the microscope. From a study of a cell to a Public Policy", Conference to the Chilean Academy of Medicine, december 2016.
Published as Hypertension, the kidney under the microscope. From a study of a cell to a Public Policy, Boletin Academia Chilena de Medicina LIII: 179-197, 2016
4. A large number of interviews, radio broadcast, television, and newspapers on public education and food label information about the benefits of low sodium/high potassium natural food for prevention of hypertension and cardiovascular diseases.

Publicaciones sobre Política de Ciencia, Postgrados, Innovación y Tecnología.
1. Vio CP. Más Interacción. I+D+i= +CHILE. Revista Universitaria 95:26-30, 2007
2. Vio CP, Williamson C. Costos Indirectos de la Investigación Científica y Tecnológica: ¿Quién paga la cuenta?. Revista Administración y Economía UC, 62:18-21, 2006
3. Vio CP. Estudios de Posgrado en Chile, Un Análisis Crítico. La Educación Superior en Chile II, Anales del Instituto de Chile, vol XXV pp 15-35, 2006
4. Rosso P, Guesalaga A, Vio CP. Investigación en las Universidades Chilenas: Realidades y Desafíos. La Educación Superior en Chile, Anales del Instituto Chile, vol XXIV pp 195-214, 2005
5. Rodríguez C, Vio CP. Necesidades de Posgraduados en Chile. Calidad en la Educación (CSE) “Estudios de Posgrado. Perspectivas y desafíos” pp.21 – 37, 2003.
6. Vio CP. Investigación y Postgrado en la Pontificia Universidad Católica, los desafíos presentes. Revista Universitaria UC 72: 41 – 43, 2001


Premios y Distinciones

  •   Miembro Correspondiente

    ACADEMIA CHILENA DE MEDICINA

    Chile, 2016

    Incorporación como Miembro Correspondiente a la Academia Chilena de Medicina por su contribución al progreso de la medicina con sus descubrimientos en la patogénesis, progresión y tratamiento de hipertensión arterial, enfermedades renales y diabetes.


 

Article (89)

Canonical Wnt Signaling Modulates the Expression of Pre- and Postsynaptic Components in Different Temporal Patterns
Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-beta
Fetal Programming of Renal Dysfunction and High Blood Pressure by Chronodisruption
Potassium Intake Prevents the Induction of the Renin-Angiotensin System and Increases Medullary ACE2 and COX-2 in the Kidneys of Angiotensin II-Dependent Hypertensive Rats
Blockade of Bradykinin receptors worsens the dystrophic phenotype of mdx mice: differential effects for B1 and B2 receptors
Bradykinin Stimulates Renal Na+ and K+ Excretion by Inhibiting the K+ Channel (Kir4.1) in the Distal Convoluted Tubule
Imbalance in renal vasoactive enzymes induced by mild hypoxia: Angiotensin-converting enzyme increases while neutral endopeptidase decreases
Long-Term, Fructose-Induced Metabolic Syndrome-Like Condition Is Associated with Higher Metabolism, Reduced Synaptic Plasticity and Cognitive Impairment in Octodon degus
Hipertension, el riñón bajo el microscopio. Desde una célula a una Política Pública en Salud
Angiotensin II increases fibronectin and collagen I through the beta-catenin-dependent signaling in mouse collecting duct cells
B-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats.
beta-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats
Fructose consumption reduces hippocampal synaptic plasticity underlying cognitive performance
N-domain angiotensin-I converting enzyme is expressed in immortalized mesangial, proximal tubule and collecting duct cells.
The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease
Basic fibroblast growth factor reduces functional and structural damage in chronic kidney disease
NFAT5 Is Protective Against Ischemic Acute Kidney Injury
PGE(2) EP3 receptor downregulates COX-2 expression in the medullary thick ascending limb induced by hypertonic NaCl
Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-beta signalling
Role of Wnt Signaling in Tissue Fibrosis, Lessons from Skeletal Muscle and Kidney
Role of Wnt signaling in tissue fibrosis, lessons from skeletal muscle and kidney.
Sildenafil Stimulates and Dexamethasone Inhibits Pulmonary Vascular Development in Congenital Diaphragmatic Hernia Rat Lungs
Angiotensin II-Independent Upregulation of Cyclooxygenase-2 by Activation of the (Pro) Renin Receptor in Rat Renal Inner Medullary Cells
Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure
Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2)
Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles
Cyclooxygenase-2 and hypoxia-regulated proteins are modulated by basic fibroblast growth factor in acute renal failure
Eicosanoids and tumor necrosis factor-alpha in the kidney.
Prostaglandin E-2 EP3 receptor regulates cyclooxygenase-2 expression in the kidney
Megalin/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: Implications for PPARs roles in renal function.
Megalin/LRP2 Expression Is Induced by Peroxisome Proliferator-Activated Receptor -Alpha and -Gamma: Implications for PPARs' Roles in Renal Function
Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model
Renin-angiotensin system may trigger kidney damage in NOD mice
E Prostanoid-1 receptor regulates renal medullary alpha ENaC in rats infused with angiotensin II
Diabetes induces changes of catecholamines in primary mesangial cells
Early expression of monocyte chemoattractant protein-1 correlates with the onset of isoproterenol-induced cardiac fibrosis in rats with distinct angiotensin-converting enzyme polymorphism
Inhibition of bFGF-receptor type 2 increases kidney damage and suppresses nephrogenic protein expression after ischemic acute renal failure
Catecholamine production along the nephron
Characterization of a long-term rat mTAL cell line
Effect of ischemic acute renal damage on the expression of COX-2 and oxidative stress-related elements in rat kidney
Pregnant rats treated with a serotonin precursor have reduced fetal weight and lower plasma volume and kallikrein levels
bFGF induces an earlier expression of nephrogenic proteins after ischemic acute renal failure
Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells
Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins
Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure
Bradykinin regulates cyclooxygenase-2 in rat renal thick ascending limb cells
Renal and hormonal effects of water deprivation in late-term pregnant rats
Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases
Mesangial cells are able to produce catecholamines in vitro
Pregnant rats with 5/6 nephrectomy have normal volume expansion despite lower renin and kallikrein
Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy
Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy
TNF alpha-regulates renal COX-2 in the rat thick ascending limb (TAL)
Aquaporin-2, a regulated water channel, is expressed in apical membranes of rat distal colon epithelium
Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity
Induction of cyclooxygenase-2 in thick ascending limb cells by adrenalectomy
Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent
Renal cyclooxygenase-2 - Evidence for recruitment of thick ascending limb of Henle cells in microdissected nephron segments
Renal phenotype of low kallikrein rats
Sterol carrier protein 2 gene transfer changes lipid metabolism and enterohepatic sterol circulation in mice
Long-term nitric oxide synthase inhibition in rat pregnancy reduces renal kallikrein.
Postnatal development of cyclooxygenase-2 in the rat kidney.
Cellular and functional aspects of the renal kallikrein system in health and disease.
Cellular distribution of exogenous aprotinin in the rat kidney
Cellular distribution and fate of the bradykinin antagonist HOE 140 in the rat kidney. Colocalization with the bradykinin B2 receptor
Postnatal maturation of tissue kallikrein-producing cells (connecting tubule cells) in the rat kidney: a morphometric and immunohistochemical study
Stimulation of the kallikrein-kinin system by pregnancy may help restore renal vasodilator response to glycine in Dahl salt-sensitive rats.
Cellular mechanisms of estrogen- and dopamine-induced control of glandular kallikrein in the anterior pituitary of the rat
Localization of Immunoreactive Tissue Kallikrein in Human Trachea
Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat.
Hormonal regulation of pituitary glandular kallikrein: a morphometric study
Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives
Decreased kallikrein excretion in renal transplant treated with cyclosporine A
Effect of cyclosporine A on the distal nephron: the use of kallikrein as a specific morphological marker.
Localization of immunoreactive glandular kallikrein in lactotrophs of the rat anterior pituitary
Immunocytochemical identification of glandular kallikrein in the rat anterior pituitary
Kallikrein excretion in patients with nephritic and nephrotic syndromes
Evidence for a stimulatory effect of high potassium diet on renal kallikrein.
Kallikrein excretion: relationship with maturation and renal function in human neonates at different gestational ages.
Synthesis and expression of functional angiotensin II receptors in Xenopus oocytes injected with rat brain mRNA
Subcellular localization of renal kallikrein by ultrastructural immunocytochemistry
Immunoreactive kallikrein localization in the rat kidney: an immuno-electron-microscopic study.
Urinary kallikrein activity in a hyporeninemic hypoaldosteronism syndrome
Visualization of renal kallikrein in luminal and basolateral membranes: effect of the tissue processing method.
Prostaglandins as mediators and modulators of the kallikrein-kinin system
Renal kallikrein in venous effluent of filtering and non-filtering isolated kidneys
Dexamethasone, Aldosterone and Kallikrein Release by Isolated Rat Kidney
Kallikrein-kinin and renin-angiotensin systems in renovascular hypertension in rats

Abstract (35)

Activation of EP3 receptors suppresses COX-2 in thick ascending limb (TAL) and inhibits water excretion
The activation of the(Pro)renin receptor (PRR) stimulates fibrotic factors expression independent of b-catenin signaling pathway in collecting duct cells
Prostaglandin E2 EP3 Receptor Downregulates COX2 Expression in the Medullary Thick Ascending Limb (mTAL) Induced by Hypertonic NaCl Intake
Boldine treatment ameliorates kidney damage in rats with 5/6 nephrectomy chronic renal failure
Activation of the Prorenin Receptor Contributes to the Ang II Mediated Increase in Cyclooxygenase-2 Expression in the Inner Medulla
Angiotensin-(1-7) Ameliorates and Prevents Expression of Fibrosis Related Genes, Tubulointerstitial Cell Infiltration and Renal Fibrosis in Unilateral Ureteral Obstruction
Prostaglandin E2 EP3 Receptor Regulates Cyclooxygenase-2 Expression in the Kidney
Effect of COX-2 inhibition on sodium excretion and ENaC expression in Angiotensin II induced hypertensive rats
Effect of Hyperhomocysteinemia on the Expression of Components of the Kallikrein-Kinin and Renin Angiotensin Systems in Rat Kidney
Prenatal Hyperglycemia Alters Renin and Kallikrein Response to High Sodium Diet in Adult Rats
Prenatal hyperglycemia alters kallikrein activity response to high sodium diet in adult rats
Epithelial sodium channel (ENaC) expression in renovascular hypertension and possible regulation by Cox-2
Mechanism of persistent alterations after recovery of acute renal failure: Contribution of kallikrein and Cyclooxygenase-2
Recombinant protein bFGF induces earlier expression of developmental morphogenes in rat acute renal failure
Angiotensin-I converting enzyme in tissues from the non-obese diabetic mouse
Pulmonary vascular development is delayed in nitrofen-induced congenital diaphragmatic hernia (CDH) in fetal rats
Cyclooxygenase-2 is induced by bradykinin in vascular smooth muscle cells
Hydralazine can prevent 5hydroxy-tryptophan-induced acute renal failure in rats.
Renal angiotensin II upregulation and myofibroblast activation in human membranous nephropathy.
Angiotensin converting enzyme (ACE) is upregulated in the tubulointerstitium of human diabetic nephropathy (DN).
Catecholamine production by distal tubular cells
Angiotensin I-converting enzyme is induced in the tubulointerstitium of hypertensive kidneys.
Catecholamine production by distal tubular cells.
Increased angiotensin I-converting enzyme and decreased kallikrein in kidneys from salt-sensitive hypertension induced by catecholamines.
Localization and regulation of cyclooxygenase-2 along microdissected nephron segments.
Regulation of Renal Cyclooxygenase-2: Effect of Angiotensin II and Bradykinin
Volume expansion in pregnant rats with chronic renal failure (CRF) or reduced uterine perfusion pressure (RUPP)
Differential distribution of cyclooxygenase 2 and glucocorticoid receptors in thick ascending limb of Henle's loop
Expression of aquaporin-2 in the rat colon: effect of thirsting
Fate and metabolism of exogenous aprotinin in the kidney
Glucocorticoids regulate the expression of cyclooxygenase-2 in the kidney
Mesangial cells (MC), LLC-PK1 and inner medullary collecting duct (IMCD) cells are able to produce catecholamines in vitro
Regulation of cyclooxygenase-2 in the kidney: a shift in the paradigm
Renal identification of angiotensin converting enzyme in the maturing rat kidney
Up-regulation of cyclooxygenase-2 in patients with ulcerative colitis: Effect of short-term pharmacological treatment.

BookSection (10)

Hipertensión Arterial: Aspectos Fisiológicos y Fisiopatológicos
Inhibidores de Enzima Convertidora de Angiotensina y Bloqueadores de Receptores de Angiotensina II
Sistema Calicreina Cininas y mediadores en la Patogenia de la Hipertensión Arterial
Cyclooxygenase is Expressed Functionally in the Renal Thick Ascending Limb Via Angiotensin II Stimulation of Tumor Necrosis Factor a
Could Kinins Contribute to the Vasculoprotective Effect of Potassium Supplementation?
Contribución del Sistema Calicreina Cininas a la regulación de la función renal y cardiovascular
Renal Kallikrein
Sistema Calicreina Cininas, Prostaglandinas e Hipertensión
Correlation between arterial wall synthesis of prostaglandins and blood pressure in spontaneously hypertensive rats
Relationship between sodium concentration and kallikrein release in the isolated rat kidney

BookWhole (1)

Fisiología Renal y Metabolismo Hidrosalino

ConferencePaper (1)

Renal identification of Cyclooxygenase-2 in a subset of thick ascending limb cells

ConferencePoster (10)

Cyclooxygenase-2 increases its expression by recruitment of neighboring epithelial cells from the thick ascending limb of Henle.
Dietary potassium regulates renal kallikrein, renin and cyclooxygenase-2: Morphological evidence.
Antifibrotic Effect of High Potassium Intake in Dystrophic Muscle: Role of Vasoactive Peptides
Dietary Potassium a Neglected Factor in Hypertension: Morphofunctional Evidence for Regulation of Cyclooxygenase-2 and Kallikrein by Potassium
High potassium intake improves strength and reduces skeletal muscle fibrosis in dystrophic mice
The (Pro)renin receptor (PRR) activation by recombinant prorenin stimulates fibrotic factors expression independent of β-catenin signaling pathway in collecting duct cells.
Dietary potassium regulates sodium excretory and vasodilatory vasoactive systems.
Proof of concept study: High potassium intake improves skeletal muscle fibrosis in dystrophic mice.
REGULATION OF RENAL CYCLOOXYGENASE-2: FROM INDUCIBLE TO REGULATED.
Fetal programming of renal function and blood pressure by maternal circadian disruption.

Proyecto (28)

Papel del Sistema Calicreina Cinina an la Fibrosis de Músculo Distrófico.
Regulation of Cyclooxygenase-2 and related Vasoactive Systems in Health and Renal Diseases and Hypertension
Regulation of Cyclooxygenase-2 and related Vasoactive Systems in Health and Renal Diseases and Hypertension.
Novel Antifibrotic Role of The ACE2/Angiotensin 1-7/Mas Axis in Skeletal Muscular Dystrophies
Novel Antifibrotic Role of The ACE2/Angiotensin 1-7/Mas Axis in Skeletal Muscular Dystrophies.
Botanic drug (botanical drug for the US FDA) for the treatment of chronic diseases associated with high national and global incidence of fibrosis
Center of Aging and Regeneration
Centro de Envejecimiento y Regeneración.
Chronic Renal Disease and Arterial Hypertension: Participation of Cyclooxygenase-2 and Angiotensin 1-7
Droga botánica (botanical drug para la FDA de EEUU) para el tratamiento en enfermedades crónicas asociadas a fibrosis de alta incidencia nacional y mundial.
Enfermedad Renal Crónica e Hipertensión Arterial=> Participación de Ciclooxigenasa-2 y Angiotensina 1-7.
Fetal Programming of Arterial Hypertension: Contribution of Renal Vasoactive Systems and Gender-Specific Differences
Alteración de Ciclooxigenasa-2 y Calicreina renal=> Contribución a la progresión de la enfermedad renal crónica e hipertensión arterial.
Alteration of Cyclooxygenase-2 and Renal kallikrein: Contribution to the progression of chronic kidney disease and arterial hypertension
Expression of nephrogenic proteins as a repair model in the regeneration phase of acute renal failure
Renal vasoactive enzymes: Cyclooxygenase-2, Angiotensin I Converting Enzyme, Kallikrein. Contribution to normal and pathological renal function
Regulation of plasma volume during gestation. Involvement of the Aquaporins and the kallikrein-kinin and renin-angiotensin systems
Regulation of Renal Cyclooxygenase-2
Morphophysiology of the Renal Kallikrein System and Mediators: Participation in Renal Excretion of Sodium and Arterial Hypertension
Determinants of Renal Kallikrein system activity under normal and pathological conditions: Cellular identification and regulation of Kininase II, Cyclooxygenase 1 and 2, and Bradykinin receptors
Pathologic ventricular hypertrophy: involvement of the renin angiotensin and adrenergic system through growth factors
Contribution of the kallikrein kinins system to normal and pathological renal function: Morphofunctional study
Tissue Vasoactive Hormones and Progression of Ventricular Hypertrophy and Hypertension
Localization and regulation of tissue kallikrein
Use of enzymatic markers in the evaluation of functional tubular mass and as an index of damage and prognosis of renal tubular lesions
Pre-eclampsia and idiopathic fetal growth retardation: possible contribution of vasoactive hormones
Ultrastructural Localization of Renal Kallikrein
Ultrastructural Localization of Renal Kallikrein and its Morphofunctional Correlation

Review (4)

P2C-Type ATPases and Their Regulation
N-domain angiotensin-I converting enzyme is expressed in immortalized mesangial, proximal tubule and collecting duct cells
Role of Wnt signaling in tissue fibrosis, lessons from skeletal muscle and kidney
Eicosanoids and tumor necrosis factor-alpha in the kidney
166
Carlos Vio

Profesor

Fisiologia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

34
Carlos Cespedes

Tecnologo Medico

Fisiologia

P. Universidad Católica de Chile

Santiago, Chile

8
Nibaldo Inestrosa

Full Professor

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

7
Alexis Gonzalez

Adjunct Professor

Instituto de Química

Pontificia Universidad Católica de Valparaiso

Valparaíso, Chile

5
Enrique Brandan

Profesor Titular

Biología Celular y Molecular

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

4
Carlos Irarrazabal

Full Professor

Fisiología

Universidad de Los Andes

Santiago, Chile

3
Daniel Cabrera

Investigador Adjunto

Gastroenterología

Pontificia Universidad Catolica de Chile

santiago, Chile

3
Claudio Cabello

Full Professor

Ciencias Biologicas

UNIVERSIDAD ANDRES BELLO

Santiago, Chile

3
Pedro Cisternas

Investigador Asociado

Biología Celular

Pontificia Universidad Católica de Chile

Santiago, Chile

2
Fernando Figueroa

Director

Medicina

UNIVERSIDAD DE LOS ANDES

Santiago de Chile, Chile

2
Eduardo Aranda

Biochemist

Hematology

P. UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

2
Diego Mezzano

Director

Hematology-Oncology

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
Juan Miquel

Full Professor

Gastroenterology

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

2
Patricio Downey

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE DEPARTAMENTO DE NEFROLOGIA

SANTIAGO, Chile

2
Attilio Rigotti

Full Professor

Nutrition, Diabetes and Metabolism

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE - ESCUELA DE MEDICINA - DEPTO DE GASTROENTEROLOGÍA

Santiago, Chile

2
Natalia Mendez

Profesor Auxiliar

UNIVERSIDAD AUSTRAL DE CHILE

valdivia, Chile

2
J Daniel Carpio

Director Ejecutivo-Profesor Asociado

Unidad Microscopía Electrónica

Universidad Austral de Chile

Valdivia, Chile

2
Alvaro González

Jefe de Departamento y División de Pediatría

Pediatría

Pontificia Universidad Católica de Chile

Santiago, Chile

2
Luis Cid

Principal Research

Laboratorio Biología Molecular

CENTRO DE ESTUDIOS CIENTIFICOS CECs

Valdivia, Chile

2
María Acuña

Directora de Investigación, académico e investigador

Universidad Bernardo O´Higgins

Santiago, Chile

1
Salesa Barja

Médico Nutrióloga pediátrica

Gastroenterología y Nutrición Pediátrica

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Maria Ocaranza

Asociate Professor

Cardiovascular Diseases Division

Pontificia Universidad Catolica de Chile

Santiago, Chile

1
Francisco Sepúlveda

Research

Laboratorio Biología Molecular

CENTRO DE ESTUDIOS CIENTÍFICOS (CECS)

Valdivia, Chile

1
Hugo Olguin

Profesor Asociado

Biología Celular y Molecular

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Lorena Salazar

Academico

Instituto Cs Biomédicas

Universidad Autónoma de Chile

Santiago, Chile

1
Sergio Mezzano

Catedratico

Medicina

Universidad Austral de Chile

Valdivia, Chile

1
Hugo Olguin

Profesor Asociado

Biología Celular y Molecular

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Maria Paz Marzolo

Profesor Titular

Departamento de Biología Celular y Molecular

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE, FAC. CIENCIAS BIOLOGICAS, DEPTO. BIOLOGIA

Santiago, Chile

1
Lorena Varela

Assistant Professor

Biological Sciences

Universidad Andres Bello

Santiago, Chile

1
Rodrigo Valenzuela

Postdoctorado

Oftalmología

Universidad de Chile

Santiago, Chile

1
Juan Rivera

Investigador

Instituto Milenio de Inmunología e Inmunoterapia

Santiago, Chile

1
Claudio Flores

Académico

Medicina

UNIVERSIDAD AUSTRAL DE CHILE

Valdivia, Chile

1
Leopoldo Ardiles

Profesor Titular

Medicina

UNIVERSIDAD AUSTRAL DE CHILE

Valdivia, Chile

1
José Erpel

SUBDIRECTOR DE ESCUELA

SALUD

DUOC UC

SANTIAGO, Chile

1
Luis Michea

PROFESOR ASOCIADO

PROGRAMA FISIOLOGIA Y BIOFISICA

UNIVERSIDAD DE CHILE

Santiago, Chile

1
Mauricio Sandoval

Lab Manager

Facultad de Medicina

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Flavio Carrion

Director Científico, Programa de Inmunología Traslacional. Director Doctorado en Ciencias e Innovación en Medicina. ICIM, Facultad de Medicina

Facultad de Medicina

Universidad del Desarrollo

Santiago, Chile

1
Attilio Rigotti

Full Professor

Nutrition, Diabetes and Metabolism

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Silvana Zanlungo

Full Professor

Gastroenterology

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Daniela Rebolledo

Académico

Centro de Excelencia en Biomedicina de Magallanes

Punta Arenas, Chile

1
Jorge Jalil

FULL PROFESSOR

ENFS CARDIOVASCULARES

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE, ESCUELA DE MEDICINA

Santiago, Chile

1
Yaneisi Vazquez

Directora técnica de proyectos

Genética Molecular

Pontificia Universidad Católica de Chile

Santiago, Chile

1
MARCO ARRESE

FULL PROFESSOR

GASTROENTEROLOGY

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Rodrigo Iturriaga

Chairman of the Department of Physiology

Physiology

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

1
Sergio Lavandero

Director

Advanced Center for Chronic Diseases (ACCDiS)

UNIVERSIDAD DE CHILE, FAC CIENCIAS QUÍMICAS Y FARMACÉUTICAS

Santiago, Chile

1
Carlos Spichiger

Profesor Adjunto

Facultad de Ciencias

UNIVERSIDAD AUSTRAL DE CHILE

Valdivia, Chile

1
David González

Investigador postdoctoral

Institut des Neurosciences de Montpellier (INM)

Montpellier, Francia

1
Ioram Jacubovsky

Médico Cirujano

Servicio de Cirugía

Hospital Dr. Sótero Del Río

Santiago, Chile

1
Hans Richter

Profesor Titular

Facultad de Medicina

Universidad Austral de Chile

Valdivia, Chile

1
Rocío Retamales

Docente

Facultad de Ciencias Agropecuarias

Universidad Pedro de Valdivia

Santiago, Chile